Parasite study paves way for infection therapies

October 10, 2017, University of Edinburgh

Fresh insight into how a harmful parasite harnesses the energy it needs to function could point towards therapies to prevent potentially fatal diseases.

New understanding of the infectious parasite, known as leishmania – which is spread by biting sandflies – points towards ways to limit its impact. The findings could help curb related infections, which cause a million cases of disease and kill 20,000 to 30,000 people around the world each year.

Crystal imaging

Researchers used sophisticated imaging techniques to show how drugs could be designed to kill the parasite by targeting a key linked to its metabolism. A team from the University of Edinburgh studied how activity in this enzyme, called LmFBPase, is controlled by another molecule known as AMP.

Using crystal structures, they revealed the by which AMP prevents the enzyme from functioning. Scientists compared this to the equivalent process in humans, and found that it works in a slightly different way.

Treatment opportunity

AMP binds differently to the enzyme in humans compared with in . These differences provide opportunities to develop molecules that would target the enzyme in parasites, but would have no effect on people. The study, published in the Journal of Molecular Biology, was supported by Wellcome, the Scottish University Life Sciences Alliance and the Biotechnology and Biological Sciences Research Council.

"Our detailed studies show how drugs might be developed to target these deadly parasites, without causing additional harm to affected people," says Professor Malcolm Walkinshaw.

Explore further: Enzyme discovery paves way to tackling deadly parasite diseases

More information: Meng Yuan et al, Structures of Leishmania Fructose-1,6-Bisphosphatase Reveal Species-Specific Differences in the Mechanism of Allosteric Inhibition, Journal of Molecular Biology (2017). DOI: 10.1016/j.jmb.2017.08.010

Related Stories

Malaria: Drug candidate may reduce spread of the parasite

September 6, 2017

Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often ...

What parasites eat is the key to better drug design

August 4, 2011

A new study has revealed in unprecedented detail how parasites use different nutrients needed for growth, providing University of Melbourne researchers with unique drug targets against Leishmania, a tropical parasite that ...

Fighting malaria through metabolism

March 23, 2017

EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite. The model offers unprecedented tools for developing a new generation of antimalarial therapies to overcome drug resistance.

Recommended for you

Researchers make coldest quantum gas of molecules

February 21, 2019

JILA researchers have made a long-lived, record-cold gas of molecules that follow the wave patterns of quantum mechanics instead of the strictly particle nature of ordinary classical physics. The creation of this gas boosts ...

Sculpting stable structures in pure liquids

February 21, 2019

Oscillating flow and light pulses can be used to create reconfigurable architecture in liquid crystals. Materials scientists can carefully engineer concerted microfluidic flows and localized optothermal fields to achieve ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.